At-home Breast Oncology Care Delivered With E-health Solutions

Status Recruiting

Clinical Trial Summary

The COVID-19 pandemic has significantly impacted healthcare service delivery, highlighting the need for high quality virtual patient care. Our team has developed a multi-dimensional remote eHealth solution for newly diagnosed breast cancer patients and their practitioners to use during the diagnostic and follow-up period. The ABODE study involved development of a Breast Cancer Treatment Application (app) which will facilitate virtual consultations, deliver patient education material, and collect patient reported outcome measures (PROMs). Using a randomized controlled trial design, the team will evaluate a variety of outcomes for breast cancer patients who will use the app throughout their diagnosis and treatment period. Primary Objective: To compare changes in patient activation (assessed by PAM-13) over 1 year among newly diagnosed breast cancer patients between those using the app and those receiving standard care. Secondary Objectives: 1. Compare additional PROMs between the standard care and intervention groups 2. Describe health service outcomes among app users 3. Explore end-user experience of using the app 4. Measure activity levels using wearable devices

Clinical Trial Description

To measure the effect of the app compared to the standard care approach, the study team will conduct a randomized controlled trial of 200 newly diagnosed breast cancer patients seen at a tertiary care cancer centre in Ontario, Canada. The intervention group (n=100) will receive access to the app in addition to standard care for 13 months following their diagnosis. The control group (n=100) will have standard care. Both arms will be provided with a Fitbit wearable device. The PAM-13 scale assesses patient activation, defined as the knowledge and confidence a patient has in self- management of one's health. Research team will test whether use of the app improves PAM-13 scores at the 12-month follow-up. Additionally, secondary outcomes will be assessed with data from additional patient-reported outcome measures (PROMs), chart review, hospital administrative databases, and Fitbits. All participants will complete PROMs at baseline, 6- and 12- months post diagnosis via REDCap survey links sent through email. The intervention group will have access to the app for 13 months following randomization. ;

Study Design

Related Conditions & MeSH terms

Neoplasms
Patient Activation
Patient Engagement
Patient Reported Outcome Measures

Clinical Trial Details

NCT number	NCT05989477
Study type	Interventional
Source	University Health Network, Toronto
Contact	Tulin Cil, MD, MEd
Phone	416-946-4507
Email	tulin.cil@uhn.ca
Status	Recruiting
Phase	N/A
Start date	June 22, 2023
Completion date	June 22, 2026

View Details

See also
Status	Clinical Trial	Phase
Completed	`NCT05110508` - Active KC: a Text Message Based Intervention for Physical Activity	N/A
Completed	`NCT06081660` - Advance Care Planning for Older Latinos With Chronic Illness	N/A
Not yet recruiting	`NCT05450445` - myHealthHub for Older Adult Inpatients	N/A
Completed	`NCT04153266` - Oral Epithelial Dysplasia Informational Needs Questionnaire
Completed	`NCT05100979` - Patient-Clinician Communication Skill Training: A Mobile Education Initiative	N/A
Recruiting	`NCT04055311` - Recovery Support for Bladder Cancer Patients and Caregivers	N/A
Recruiting	`NCT05155150` - Improving Shared-Decision Making in the Intensive Care Unit Using Patient-reported Outcome Information	N/A
Completed	`NCT04971278` - Evaluating the Impact of a Supportive Care Program
Completed	`NCT04687943` - Comparison of PELOID Therapy and Kinesio Tape Effectiveness in Patients With Lateral Epicondylitis
Recruiting	`NCT06156449` - Effect of Thyme Oil on Respiratory Symptoms and Hemodynamic Parameters in COPD Patients	N/A
Active, not recruiting	`NCT05353049` - How to Bathe a Person With Dementia? A Bathing Intervention Based on Basale Stimulation® for People With Moderate to Severe Dementia	N/A
Completed	`NCT05280171` - Impact of Teach Back of Discharge Information in Term of Patient Recall of Information and Patient Engagement	N/A
Recruiting	`NCT04892927` - NCI SBIR Contract for Patient Navigation Tool Prototype Development
Completed	`NCT05091918` - Limited Market Release - MotionSense Clinical Use Evaluation	N/A
Terminated	`NCT04790773` - Alexa, What is Eliquis and Xarelto?	N/A
Completed	`NCT04638127` - PREEMIE PROGRESS: A Family Management Program for Parents of Preterm Infants	N/A
Not yet recruiting	`NCT04249518` - Video Extradition of Continuous Positive Airway Pressure - Influence on Compliance	N/A
Not yet recruiting	`NCT06195839` - Building Engagement Using Financial Incentives Trial - Hypertension	N/A
Recruiting	`NCT05086406` - Virtual and Video Counseling Versus In-Office Counseling for Laparoscopic Hysterectomy	N/A
Not yet recruiting	`NCT05732779` - Mobile Video Directly Observed Therapy (DOT) for Immunosuppression Medication Adherence in Adolescent Heart Transplant Recipients	N/A

Clinical trials are conducted in a series of steps, called phases - each phase is designed to answer a separate research question.

Phase 1: Researchers test a new drug or treatment in a small group of people for the first time to evaluate its safety, determine a safe dosage range, and identify side effects.
Phase 2: The drug or treatment is given to a larger group of people to see if it is effective and to further evaluate its safety.
Phase 3: The drug or treatment is given to large groups of people to confirm its effectiveness, monitor side effects, compare it to commonly used treatments, and collect information that will allow the drug or treatment to be used safely.
Phase 4: Studies are done after the drug or treatment has been marketed to gather information on the drug's effect in various populations and any side effects associated with long-term use.

At-home Breast Oncology Care Delivered With E-health Solutions — ABODE

Clinical Trial Summary

Clinical Trial Description

Study Design

Related Conditions & MeSH terms